Table 1.
The functions of m6A enzymes in the angiogenesis of various cancers
| Type | Molecule | Role in tumors | Tumor type | Mechanism | References |
|---|---|---|---|---|---|
| Writers | METTL3 | Oncogene | Bladder cancer | Promote angiogenesis via modulating TEK and VEGF-A | [72] |
| Oncogene | GC | Promote angiogenesis via stimulating m6a modification of HDGF mRNA | [58] | ||
| Oncogene | HCC | Promote angiogenesis via modulating Hippo pathway | [57] | ||
| Oncogene | RCC | Promote angiogenesis via modulating HIF-2α | [73] | ||
| METTL14 | Oncogene | Breast cancer | Promote angiogenesis via modulating VEGFA and RhoA and PI3K-Akt pathways | [27] | |
| Erasers | FTO | Suppressor gene | ICC | FTO expression is inversely correlated with MVD. | [45] |
| ALKBH5 | Oncogene | Breast cancer | Promote angiogenesis via modulating VEGFA and RhoA and PI3K-Akt pathways | [27] | |
| Readers | IGF2BP2 | Oncogene | Lung cancer | Promote angiogenesis via modulating HNF4G/IGF2BP2/TK1 axis | [74] |
| IGF2BP3 | Oncogene | GC | Promote angiogenesis via enhancing HDGF mRNA stability | [58] | |
| Oncogene | CRC | Promote angiogenesis via modulating VEGF | [39] | ||
| Oncogene | GBM | Promote angiogenesis via modulating PI3K/MAPK pathways | [75] | ||
| YTHDF1 | Oncogene | GC | Promote angiogenesis via modulating Wnt/β-catenin pathway | [32] | |
| YTHDF2 | Suppressor gene | HCC | Suppress angiogenesis via downregulating IL11 and SERPINE2 | [70] | |
| YTHDF3 | Oncogene | Breast cancer | Promote angiogenesis via modulating VEGFA and EGFR | [71] |